Immune Imprinting and Antibody Profiles to SARS-CoV-2 in Urban and Rural Ghana

Description

Infections with SARS-CoV-2 and the development of immunity to the virus and its antigenic variants have been unevenly documented globally, with African populations particularly understudied. As SARS-CoV-2 transitions towards being an endemic pathogen, more nuanced understanding of immune protection in diverse populations is required. In 2023, we conducted a cross-sectional study of 1,000 Ghanaian residents to assess SARS-CoV-2 prevalence and antibody correlates of immunity against SARS-CoV-2 variants. We found an active SARS-CoV-2 infection rate of 1.3% and a 57% vaccination rate. We observed anti-SARS-CoV-2 Spike plasma antibody sero-positivity of 98.7%, with urban compared to rural residents having higher anti-SARS-CoV-2 plasma and saliva antibody concentrations. Vaccinated and urban individuals exhibited significantly greater Spike-pseudotyped virus neutralization than nonvaccinated and rural individuals. Notably, plasma antibodies preferentially bound Wuhan-Hu-1 SARS-CoV-2 over Omicron Spike variants. Our findings indicate significant prior and ongoing SARS-CoV-2 transmission as well as immunological imprinting by Wuhan-Hu-1-like SARS-CoV-2 in Ghana. Antigen and antibody data in this study were generated using electrochemiluminescence (ECL)-based Meso Scale Discovery (MSD) assays. This Mendeley dataset includes MSD Arbitrary Units derived from ECL data. Additionally, the dataset contains Spike-pseudotyped virus neutralization percentages and deidentified demographic information for the study participants, including town of residence, sex, and COVID-19 vaccination status. Age information has been excluded to maintain participant privacy.

Steps to reproduce

Detailed methods are described in iScience article: https://doi.org/10.1016/j.isci.2025.112511

Institutions

• Universitat Basel

  BS, Basel
• Stanford University

  CA, Stanford
• University of Ghana Noguchi Memorial Institute for Medical Research

  Greater Accra, Accra
• Meso Scale Diagnostics LLC

  MD, Rockville
• Schweizerisches Tropen- und Public Health-Institut

  Basel-Stadt, Basel

Categories

Funders

• Swiss National Science Foundation

  Bern, Switzerland

  Grant ID: PR00P3_208580
• State Secretariat for Education, Research and Innovation

  Bern, Switzerland

Related Links

Licence